Methyl 3-{[(5E)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}-1H-indole-2-carboxylate

Catalog No. :
ACEWQO940
CAS No. :
860612-09-5
Molecular Formula :
C14H10N2O4S
Molecular Weight :
302.31

IUPAC Name:methyl (E)-3-((2,4-dioxothiazolidin-5-ylidene)methyl)-1H-indole-2-carboxylate

Methyl 3-{[(5E)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}-1H-indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$564.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-{[(5E)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}-1H-indole-2-carboxylate
IUPAC Namemethyl (E)-3-((2,4-dioxothiazolidin-5-ylidene)methyl)-1H-indole-2-carboxylate
MDL No.MFCD05668718
Molecular FormulaC14H10N2O4S
Molecular Weight302.31
SMILESCOC(=O)C1=C(/C=C2/SC(=O)NC2=O)C2=C(C=CC=C2)N1
InChI KeyQVTYLMVJZLDILX-UXBLZVDNSA-N
SynonymMETHYL 3-[(2,4-DIOXO-1,3-THIAZOLAN-5-YLIDEN)METHYL]-1H-INDOLE-2-CARBOXYLATE;1H-Indole-2-carboxylic acid, 3-[(2,4-dioxo-5-thiazolidinylidene)methyl]-, methyl ester
CAS No.860612-09-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEWQO940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUELJ431 route compound structure diagram
    ACUELJ43118450-26-5 In Stock
  2. Plus
  3. ACOFNI502 route compound structure diagram
    ACOFNI5022295-31-0 In Stock
  4. Then
  5. ACEWQO940 route product structure diagram
    ACEWQO940860612-09-5
Inquiry

2. ACEWQO940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEWQO940 route product structure diagram
    ACEWQO940860612-09-5
Inquiry

Comments (0)